In hepatocellular carcinoma, LINC00152 appears to activate the rapamycin (mTOR) pathway by binding to the promoter of EpCAM through cis-regulation, which was confirmed by the Gal4-λN/BoxB reporter system16. The gene discussed is EPCAM; the disease is hepatocellular carcinoma.